Novel Pentameric Thiophene Derivatives for in Vitro and in Vivo Optical Imaging of a Plethora of Protein Aggregates in Cerebral Amyloidoses

Autor: Adriano Aguzzi, Peter Konradsson, Mikael Lindgren, Tristan Bolmont, Mathias Jucker, Stefan Prokop, Patrick R. Hof, Eirik Glimsdal, Stefan A. Grathwohl, K. Peter R. Nilsson, Frank L. Heppner, Christina J. Sigurdson, David M. Holtzman, Therése Klingstedt, Per Hammarström, Andreas Åslund, Sam Gandy, Dara L. Dickstein
Přispěvatelé: University of Zurich
Jazyk: angličtina
Rok vydání: 2009
Předmět:
1303 Biochemistry
Protein aggregation
Acetates
01 natural sciences
Biochemistry
chemistry.chemical_compound
Mice
Alzheimers-Disease
0303 health sciences
Brain Diseases
Molecular Structure
Chemistry
Brain
Neurodegenerative Diseases
General Medicine
Amyloidosis
Beta-peptide
Beta-Peptide
3. Good health
Molecular Medicine
Molecular probe
Amyloid
Conformational States
10208 Institute of Neuropathology
Mice
Transgenic

610 Medicine & health
Thiophenes
Thioflavin-T
010402 general chemistry
Fibril
Article
Transgenic Mice
03 medical and health sciences
Microscopy
Electron
Transmission

In vivo
Animals
Humans
030304 developmental biology
Amyloid beta-Peptides
Conjugated Polyelectrolytes
In vitro
0104 chemical sciences
Disease Models
Animal

1313 Molecular Medicine
Oligomers
570 Life sciences
biology
Fibrils
Probes
Ex vivo
Zdroj: ACS Chemical Biology; Vol 4
ISSN: 1554-8937
DOI: 10.1021/cb900112v
Popis: Molecular probes for selective identification of protein aggregates are important to advance our understanding of the molecular pathogenesis underlying cerebral amyloidoses. Here we report the chemical design of pentameric thiophene derivatives, denoted luminescent conjugated oligothiophenes (LCOs), which could be used for real-time visualization of cerebral protein aggregates in transgenic mouse models of neurodegenerative diseases by multiphoton microscopy. One of the LCOs, p-FTAA, showed conformation-dependent optical properties and could be utilized for ex vivo spectral assignment of distinct prion deposits from two mouse-adapted prion strains. p-FTAA also revealed staining of transient soluble pre-fibrillar non-thioflavinophilic Aβ- assemblies during in vitro fibrillation of Aβ peptides. In brain tissue samples, Aβ deposits and neurofibrillary tangles (NFTs) were readily identified by a strong fluorescence from p-FTAA and the LCO staining showed complete co-localization with conventional antibodies (6E10 and AT8), indicating that p-FTAA detects all the immuno-positive aggregated proteinaceous species in Alzheimer disease, but with significantly shorter imaging time (100 fold) compared to immunofluorescence. In addition, a patchy islet-like staining of individual Aβ plaque was unveiled by the anti-oligomer A11 antibody during co-staining with p-FTAA, suggesting that pre-fibrillar species are likely an intrinsic component of Aβ plaques in human brain. The major hallmarks of Alzheimer’s disease, namely Aβ aggregates versus NFTs could also be distinguished due to distinct emission spectra from p-FTAA. Overall, we demonstrate that LCOs can be utilized as powerful practical research tools for studying protein aggregation diseases and facilitate the study of amyloid origin, evolution and maturation, Aβ−tau interactions and pathogenesis both ex vivo and in vivo.
Databáze: OpenAIRE